Acta Scientific Microbiology (ISSN: 2581-3226)

Review Article Volume 5 Issue 7

Bacterial Infections in Coronavirus Disease 2019

Sabah Al-Harazi1*, Lubna Shirin2 and Mohammed Shahjahan Kabir3

1Department of Early Clinical Exposure, Faculty of Medicine, Malaysian Allied Health Sciences Academy (MAHSA) University, Malaysia

2Department of Anatomy, Faculty of Medicine, Malaysian Allied Health Sciences Academy (MAHSA) University, Malaysia

3School of Medicine, Perdana University, Royal College of Surgeons Ireland (PURCSI), Malaysia

*Corresponding Author: Sabah Al-Harazi, Department of Early Clinical Exposure, Faculty of Medicine, Malaysian Allied Health Sciences Academy (MAHSA) University, Malaysia, ORCID ID: 0000-0002-1183-089X.

Received: May 05, 2022; Published: June 06, 2022


Infections caused by bacteria, viruses, and fungi have been reported in COVID-19 patients, but data on these infections is limited. These infections are classified as either community-acquired or hospital-acquired and coinfection or secondary/superinfection. The most common hospital-acquired superinfections are ventilator-associated pneumonia, hospital-acquired pneumonia, and bacteremia. The prevalence of community-acquired bacterial pneumonia in patients with COVID-19 infection is uncommon. Co-infection with COVID-19 and tuberculosis (TB) has also been reported. Empiric antibiotics may not be required in the majority of COVID-19 patients, especially those not severely ill. Superinfections by antibiotic-resistant bacteria have also been reported among critically ill patients with COVID-19 infection.

Keywords:Bacteria; Coronavirus Disease 2019; Community-acquired Infections; Hospital-acquired Infections


  1. Garner JS., et al. "CDC definitions for nosocomial infections, 1988". AJIC American Journal of Infection Control 3 (1988): 128-140.
  2. Henderson KL., et al. "Community-acquired, healthcare-associated and hospital-acquired bloodstream infection definitions in children: a systematic review demonstrating inconsistent criteria". Journal of Hospital Infection 2 (2013): 94-105.
  3. Søgaard KK., et al. "Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia". Journal of Intensive Care1 (2021): 10.
  4. Baskaran V., et al. "Co-infection in critically ill patients with COVID-19: an observational cohort study from England". Journal of Medical Microbiology4 (2021): 001350.
  5. Garcia-Vidal C., et al. "Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study". Clinical Microbiology and Infection 1 (2021): 83-88.
  6. Woo Joo Kwon, et al. "Superinfections and Coinfections in COVID-19".| MedPage Today (2020).
  7. Huang C., et al. "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China". Lancet10223 (2020): 497-506.
  8. Zhu X., et al. "Co-infection with respiratory pathogens among COVID-2019 cases". Virus Research 285 (2020): 198005.
  9. Lai C-C., et al. "Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?". Journal of Microbiology, Immunology and Infection 4 (2020): 505-512.
  10. Lansbury L., et al. "Co-infections in people with COVID-19: a systematic review and meta-analysis". Journal of Infection2 (2020): 266-275.
  11. Musuuza J., et al. "Prevalence and outcomes of co-infection and super-infection with SARS-CoV-2 and other pathogens: A Systematic Review and Meta-analysis". PLoS One5 (2021): e0251170.
  12. Langford BJ., et al. "Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis". Clinical Microbiology and Infection 12 (2020): 1622-1629.
  13. National Institute for Health and Care Excellence (NICE). "COVID-19 rapid guideline: Managing COVID-19". (2022).
  14. Nasir N., et al. "Risk factors for bacterial infections in patients with moderate to severe COVID-19: A case-control study". Journal of Medical Virology7 (2021): 4564-4569.
  15. He Y., et al. "Nosocomial infection among patients with COVID-19: A retrospective data analysis of 918 cases from a single center in Wuhan, China". Infection Control and Hospital Epidemiology 8 (2020): 982-983.
  16. Puzniak L., et al. "A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19". BMC Infectious Disease1 (2021): 227.
  17. Maes M., et al. "Ventilator-associated pneumonia in critically ill patients with COVID-19". Critical Care1 (2021): 25.
  18. COVID-19 Treatment Guidelines Panel. “Coronavirus Disease 2019 (COVID-19) Treatment Guidelines”. National Institutes of Health (NIH).
  19. Contou D., et al. "Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU". Annals of Intensive Care1 (2020): 119.
  20. Tadolini M., et al. "Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases". European Respiratory Journal1 (2020): 2001398.
  21. Visca D., et al. "Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects". Pulmonology2 (2021): 151-165.
  22. World Health Organization (WHO). "Information Note Tuberculosis and COVID-19 COVID-19: Considerations for tuberculosis (TB) care" (2020).
  23. Sy KTL., et al. "Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19". Infectious Disease (Lond) 12 (2020): 902-907.
  24. Davies M-A. "HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South Africa". org - the preprint server for Health Sciences 7.2 (2020): 20145185.
  25. Mishra A., et al. "Tuberculosis and COVID-19 Co-infection: An Updated Review". Acta Biomed1 (2020): e2021025.
  26. Motta I., et al. "Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts". Pulmonology4 (2020): 233-240.
  27. Togun T., et al. "Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes”. Annals of Clinical Microbiology and Antimicrobials21 (2020): 1-6.
  28. Chen N., et al. "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study". Lancet10223 (2020): 507-513.
  29. Yang X., et al. "Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study". Lancet Respiratory Medicine5 (2020): 475-481.
  30. Zhou F., et al. "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study". Lancet10229 (2020): 1054-1062.
  31. Clancy CJ., et al. "Bacterial superinfections among persons with coronavirus disease 2019: A comprehensive review of data from postmortem studies". Open Forum Infectious Diseases 3 (2021): ofab065.
  32. Nag VL., et al. "Superinfections in COVID-19 Patients: Role of Antimicrobials". Dubai Medical Journal1 (2021): 1-10.


Citation: Sabah Al-Harazi., et al. “Bacterial Infections in Coronavirus Disease 2019". Acta Scientific Microbiology 5.7 (2022): 15-21.


Copyright: © 2022 Sabah Al-Harazi., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate30%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is April 30th, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US